Dimeric Natural Product Research Articles

Dimeric natural product panepocyclinol A inhibits STAT3 via di-covalent modification

Homo- or heterodimeric compounds that affect dimeric protein function through interaction between monomeric moieties and protein subunits can serve as valuable sources of potent and selective drug candidates. Here, we screened an in-house dimeric natural product collection, and panepocyclinol A (PecA) emerged as a selective and potent STAT3 inhibitor with profound anti-tumor efficacy. Through cross-linking C712/C718 residues in separate STAT3 monomers with two distinct Michael receptors, PecA inhibits STAT3 DNA binding affinity and transcription activity. Molecular dynamics simulation reveals the key conformation changes of STAT3 dimers upon the di-covalent binding with PecA that abolishes its DNA interactions. Furthermore, PecA exhibits high efficacy against anaplastic large T cell lymphoma in vitro and in vivo, especially those with constitutively activated STAT3 or STAT3Y640F. In summary, our study describes a distinct and effective di-covalent modification for the dimeric compound PecA to disrupt STAT3 function.

Maresin 1 alleviates sevoflurane-induced neuroinflammation in neonatal rats via JAK2/STAT3/IL-6 pathways

Developmental neurotoxicity is a serious consequence of repeated exposure to sevoflurane during the postnatal period. Neuroinflammation is closely related to sevoflurane-induced developmental neurotoxicity. The present study explored the potential effect of maresin 1 (MaR1), an anti-inflammatory agent, on neuroinflammation and neurotoxicity induced by repeated sevoflurane exposure. In this study, MaR1 ameliorated sevoflurane-induced cognitive dysfunction, Tau hyperphosphorylation, and synaptic protein reduction. The protein level of the proinflammatory factor interleukin-6 (IL-6) and its upstream regulator Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway were substantially upregulated by sevoflurane in rat brains, but downregulated after MaR1 administration. To confirm the involvement of this pathway, we used coumermycin A1 (CA1), a chemical dimeric natural product that induced dimerization and activation of JAK2, and observed that the protective effect of MaR1 against sevoflurane-induced toxicity was completely blocked, as shown by decreased synaptic protein levels and increased Tau phosphorylation. Furthermore, it confirmed by dual luciferase reporter assay that there existed a STAT3′s binding motif on the promoter sequence of IL-6. These results suggest that the protective effect of MaR1 against developmental neurotoxicity is mediated through the JAK2/STAT3/IL-6 signaling pathway and provide an experimental basis for clinical guidance on the use of sevoflurane.

ChemInform Abstract: Enantioselective Formal Syntheses of 11 Nuphar Alkaloids and Discovery of Potent Apoptotic Monomeric Analogues.

Concise, scalable, and enantioselective formal syntheses of eight dimeric and three monomeric nuphar alkaloids were achieved, along with the construction of a stereochemically diverse collection of the first known monomeric analogues having apoptotic activity. The syntheses involved the development of highly enantioselective Bronsted acid catalyzed vinylogous Mukaiyama-Mannich reactions, which feature the unprecedented use of a supersilyl group to control the regio-, enantio- and diastereoselectivity. Biological studies reveal that several of these novel nuphar analogues are even more potent than their dimeric natural product counterparts.

Enantioselective Formal Syntheses of 11 Nuphar Alkaloids and Discovery of Potent Apoptotic Monomeric Analogues

AbstractConcise, scalable, and enantioselective formal syntheses of eight dimeric and three monomeric nuphar alkaloids were achieved, along with the construction of a stereochemically diverse collection of the first known monomeric analogues having apoptotic activity. The syntheses involved the development of highly enantioselective Brønsted acid catalyzed vinylogous Mukaiyama–Mannich reactions, which feature the unprecedented use of a supersilyl group to control the regio‐, enantio‐ and diastereoselectivity. Biological studies reveal that several of these novel nuphar analogues are even more potent than their dimeric natural product counterparts.

Enantioselective Formal Syntheses of 11 Nuphar Alkaloids and Discovery of Potent Apoptotic Monomeric Analogues.

Concise, scalable, and enantioselective formal syntheses of eight dimeric and three monomeric nuphar alkaloids were achieved, along with the construction of a stereochemically diverse collection of the first known monomeric analogues having apoptotic activity. The syntheses involved the development of highly enantioselective Brønsted acid catalyzed vinylogous Mukaiyama-Mannich reactions, which feature the unprecedented use of a supersilyl group to control the regio-, enantio- and diastereoselectivity. Biological studies reveal that several of these novel nuphar analogues are even more potent than their dimeric natural product counterparts.

4,4'-Bismoschamine: biomimetic synthesis and evidence to support structural equivalency to montamine.

The dimeric natural product montamine was originally reported as two N-feruloylserotonin (moschamine) units linked by a nitrogen-nitrogen bond, but our recent synthesis of this symmetrical diacyl hydrazide structure revealed this to be incorrect. We subsequently hypothesized that the moschamine subunits were linked through the indole C4 site and that montamine was structurally identical to 4,4'-bismoschamine, a known natural product present in safflower oil. However, given that authentic samples of both montamine and 4,4'-bismoschamine were unavailable and that the NMR data for the natural products were recorded in different solvents, we were unable to unequivocally prove this hypothesis. A recent publication that claims montamine and 4,4'-bismoschamine are not the same natural product prompts us to disclose our own findings on this matter. A biomimetic synthesis of 4,4'-bismoschamine was developed that hinged on oxidative coupling of N-Boc-serotonin followed by elaboration of the resulting 4,4'-dimer to the natural product. A detailed comparison of the NMR data for synthetic 4,4'-bismoschamine with that reported for montamine revealed that while the 1H NMR data were in good agreement, the 13C NMR data displayed some discrepancies. In light of this result, the NMR data for several literature compounds was analyzed, the results of which revealed that the upfield chemical shifts of the methylene protons in the 1H NMR of montamine is unique to 4,4'-bistryptamines, supporting our initial statement that montamine and 4,4'-bismoschamine are structurally equivalent. Given that the main differences in the 13C NMR data between montamine and synthetic 4,4'-bismoschamine occur at the quaternary carbons, we propose that these peaks have been misassigned from a 13C NMR spectrum that was obtained from an impure sample and/or the small amount of montamine (4 mg) isolated from the natural source.

Structure revision of pilidiostigmin from the leaves of Pilidiostigma glabrum

The structure of the dimeric phloroglucinol natural product pilidiostigmin, previously reported from the leaves of the Australian rainforest plant Pilidiostigma glabrum, has been revised based on reinterpretation of the spectroscopic data. Pilidiostigmin is an oxidised diacyldibenzofuran. ROESY exchange correlations indicate that pilidiostigmin occurs in solution as an almost equimolar mixture of two interconverting 3-hydroxycyclohexenone tautomers.

Atropselective syntheses of (-) and (+) rugulotrosin A utilizing point-to-axial chirality transfer.

Chiral, dimeric natural products containing complex structures and interesting biological properties have inspired chemists and biologists for decades. A seven step total synthesis of the axially chiral, dimeric tetrahydroxanthone natural product rugulotrosin A is described. The synthesis employs a one-pot Suzuki coupling/dimerization to generate the requisite 2,2'-linked biaryl linkage. Highly selective point-to-axial chirality transfer was achieved using palladium catalysis with achiral phosphine ligands. Single X-ray crystal diffraction data was obtained to confirm both the atropisomeric configuration and absolute stereochemistry of rugulotrosin A. Computational studies are described to rationalize the atropselectivity observed in the key dimerization step. Comparison of the crude fungal extract with synthetic rugulotros in A and its atropisomer verified that nature generates a single atropisomer of the natural product.

Toward an asymmetric synthesis of the dimeric pyranonaphthoquinone antibiotic crisamicin A.

A full account of our efforts toward an asymmetric synthesis of crisamicin A are presented. The key steps include a Hauser-Kraus annulation of a cyanophthalide with a chiral enone-lactone, a stereoselective cyclization-reduction to install the pyran unit, and a Suzuki homocoupling to forge the key biaryl bond. This work has culminated in the asymmetric synthesis of a dimer bearing the complete carbon skeleton of the dimeric pyranonaphthoquinone natural product crisamicin A.

Formal synthesis of kingianin A based upon a novel electrochemically-induced radical cation Diels-Alder reaction.

The application of electrochemical reactions in natural product synthesis has burgeoned in recent years. We herein report a formal synthesis of the complex and dimeric natural product kingianin A, which employs an electrochemically-mediated radical cation Diels-Alder cycloaddition as the key step.

Di(phenylpropylamino)gossypol: a derivative of the dimeric natural product gossypol

Di(phenylpropylamino)gossypol [systematic name: 2,2'-bis{1,6-dihydroxy-5-isopropyl-8-[(3-phenylpropylamino)methylidene]naphthalen-7-one}, C48H52N2O6, was formed by reaction of the dimeric natural product gossypol with 3-phenylpropylamine. The structure of this compound has its two naphthalene ring systems oriented approximately perpendicular to each other, and the two pendant phenylpropyl groups have different conformations. One of these side groups is considerably disordered at room temperature but less so at 120 K. The enantiomeric molecules form centrosymmetric dimers that are supported by intermolecular hydrogen bonds and by hydrophobic interactions between a pair of naphthalene rings. Two additional hydrogen bonds tie the dimer pairs into layers. Unlike gossypol and many gossypol Schiff base derivatives, the title compound crystallizes without the inclusion of solvent, which appears to occur because of the size and flexibility of its phenylpropyl pendent groups.

Epigenetic profiling of the antitumor natural product psammaplin A and its analogues

A collection of analogues of the dimeric natural product psammaplin A that differ in the substitution on the (halo)tyrosine aryl ring, the oxime and the diamine connection has been synthesized. The effects on cell cycle, induction of differentiation and apoptosis of the natural-product inspired series were measured on the human leukaemia U937 cell line. Epigenetic profiling included induction of p21 WAF1, effects on global H3 histone and tubulin acetylation levels as well as in vitro enzymatic assays using HDAC1, DNMT1, DNMT3A, SIRT1 and a peptide domain with p300/CBP HAT activity. Whereas the derivatives of psammaplin A with modifications in the length of the connecting chain, the oxime bond and the disulfide unit showed lower potency, the analogues with changes on the bromotyrosine ring exhibited activities comparable to those of the parent compound in the inhibition of HDAC1 and in the induction of apoptosis. The lack of HDAC1 activity of analogues modified on the disulfide bond suggests that its cleavage must occur in cells to produce the monomeric Zn 2+-chelating thiol. This assumption is consistent with the molecular modelling of the complex of psammaplin A thiol with h-HDAC8. Only a weak inhibition of DNMT1, DNMT3A and residual activities with SIRT1 and a p300/CBP HAT peptide were measured for these compounds.

Dimeric Approaches to Anti-Cancer Chemotherapeutics

Numerous proteins responsible for cell proliferation and differentiation exist either as hetero or homodimers or become activated through dimerization as a key step in their respective signaling cascade. Many of these proteins have been identified as major components in oncogenic signaling pathways and have become popular targets for the development of anti-tumor agents. For this reason, bivalent anti-cancer drugs that could potentially interact with each monomer of a dimeric protein target have been developed. This review provides a brief background on prevalent dimeric drug targets within the anti-cancer field and focuses mainly on dimeric natural product and synthetic cancer chemotherapeutics.

Asymmetric synthesis of aerothionin, a marine dimeric spiroisoxazoline natural product, employing optically active spiroisoxazoline derivative

Successful first synthesis of optically pure (+)- and (−)-aerothionins ( 1 ) from the racemic spiroisoxazoline derivative 8 has been accomplished. The absolute configuration of natural (+)- 1 was determined by comparison of (+)- and (−)- 8 with related derivatives.

Synthesis of Epoxyquinol A and Related Molecules: Probing Chemical Reactivity of Epoxyquinol Dimers and 2H-Pyran Precursors

Total syntheses of the epoxyquinoid dimers, epoxyquinols A, B, and epoxytwinol A (RKB-3564 D), have been accomplished employing [4 + 2] and [4 + 4] dimerization of 2H-pyran epoxyquinol monomers. Modifications of 2H-pyran precursors have been explored, including alteration of epoxy alcohol and diene stereochemistry. A stable 2H-pyran prepared by alteration of the epoxyquinol 2H-pyran nucleus was evaluated as a diene in Diels-Alder cycloaddition with reactive dienophiles. Extensive studies for improving the [4 + 4] dimerization of selectively protected 2H-pyran monomers to afford the novel epoxyquinoid dimer epoxytwinol A were carried out, and valuable insight regarding competitive [4 + 2] and [4 + 4] dimerization processes has been obtained. In addition, chemical reactivities and structural modifications of epoxyquinol dimers have been evaluated, including [2 + 2] photocycloaddition and [3,3] sigmatropic rearrangement, indicating the possibility for production of novel structural diversity from dimeric epoxyquinoid natural product frameworks.

Total Synthesis of the Novel, Biologically Active Epoxyquinone Dimer (.+‐.)‐Torreyanic Acid: A Biomimetic Approach.

A total synthesis of the complex, biologically active, dimeric natural product (±)-torreyanic acid, which is composed of seven rings and laced with dense, variegated oxy-functionalization, has been accomplished from readily available allyl-substituted p-benzoquinone 8. Our synthetic stratagem involves crafting an epoxyquinone monomer for use in a biomimetic cascade process involving tandem a 6π electrocyclization and a Diels−Alder dimerization.

Total Synthesis of the Novel, Biologically Active Epoxyquinone Dimer (±)-Torreyanic Acid: A Biomimetic Approach

[reaction: see text] A total synthesis of the complex, biologically active, dimeric natural product (+/-)-torreyanic acid, which is composed of seven rings and laced with dense, variegated oxy-functionalization, has been accomplished from readily available allyl-substituted p-benzoquinone 8. Our synthetic stratagem involves crafting an epoxyquinone monomer for use in a biomimetic cascade process involving tandem a 6pi electrocyclization and a Diels-Alder dimerization.

Synthesis of the C1-C21 (C1'-C21') fragment of the dimeric polyketide natural product SCH 351448.

[structure: see text] A convergent, stereoselective assembly of the C1-C21 (C1'-C21') fragment of SCH 351448, a 28-membered bis-lactone natural product, has been developed. A highly efficient approach to this fragment assembles 75% of the carbon skeleton and all the stereochemical elements present in the natural product. In addition, an interesting boron ligand effect on the diastereoselectivity of a key aldol reaction with methyl ketone-derived enolborinates is reported.

A versatile synthetic route to the anti-implantation agent, yuehchukene, and its analogues

A detailed study directed toward the development of a versatile synthetic route to the interesting dimeric natural product yuehchukene (1) and its epimer, 6a-epi-yuehchukene (2), has been completed. Due to the anti-implantation activity associated with 1, it was important to provide a synthetic strategy not only to 1, but to a family of yuehchukene analogues that, hopefully, would reveal superior chemical stability and (or) elevated biological activity. The experiments described herein and which utilize the readily available and inexpensive isophorone (6) satisfy these requirements. Key words: yuehchukene synthesis, yuehchukene analogues, anti-implantation activity.

An efficient synthesis of yuehchukene

A three-step synthesis of yuehchukene 1, a novel dimeric indole natural product with anti-implantation activity via acid-catalyzed reaction of β-(3-hydroxy-3-methylbutenyl)indole is reported.